• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of jcinvestThe Journal of Clinical InvestigationCurrent IssueArchiveSubscriptionAbout the Journal
J Clin Invest. Dec 15, 1996; 98(12): 2739–2745.
PMCID: PMC507738

Relaxin induces an extracellular matrix-degrading phenotype in human lung fibroblasts in vitro and inhibits lung fibrosis in a murine model in vivo.

Abstract

Pulmonary fibrosis is the common end stage of a number of pneumopathies. In this study, we examined the ability of the human cytokine, relaxin, to block extracellular matrix deposition by human lung fibroblasts in vitro, and to inhibit lung fibrosis in a bleomycin-induced murine model. In vitro, relaxin (1-100 ng/ml) inhibited the transforming growth factor-beta-mediated over-expression of interstitial collagen types I and III by human lung fibroblasts by up to 45% in a dose-dependent manner. Relaxin did not affect basal levels of collagen expression in the absence of TGF-beta-induced stimulation. Relaxin also blocked transforming growth factor-beta-induced upregulation of fibronectin by 80% at the highest relaxin dose tested (100 ng/ml). The expression of matrix metalloproteinase-1, or procollagenase, was stimulated in a biphasic, dose-dependent manner by relaxin. In vivo, relaxin, at a steady state circulating concentration of approximately 50 ng/ml, inhibited bleomycin-mediated alveolar thickening compared with the vehicle only control group (P < 0.05). Relaxin also restored bleomycin-induced collagen accumulation, as measured by lung hydroxyproline content, to normal levels (P < 0.05). In summary, relaxin induced a matrix degradative phenotype in human lung fibroblasts in vitro and inhibited bleomycin-induced fibrosis in a murine model in vivo. These data indicate that relaxin may be efficacious in the treatment of pathologies characterized by lung fibrosis.

Full Text

The Full Text of this article is available as a PDF (635K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Sheppard MN, Harrison NK. New perspectives on basic mechanisms in lung disease. 1. Lung injury, inflammatory mediators, and fibroblast activation in fibrosing alveolitis. Thorax. 1992 Dec;47(12):1064–1074. [PMC free article] [PubMed]
  • McGowan SE. Extracellular matrix and the regulation of lung development and repair. FASEB J. 1992 Aug;6(11):2895–2904. [PubMed]
  • Bell RJ, Eddie LW, Lester AR, Wood EC, Johnston PD, Niall HD. Relaxin in human pregnancy serum measured with an homologous radioimmunoassay. Obstet Gynecol. 1987 Apr;69(4):585–589. [PubMed]
  • Chihal HJ, Espey LL. Utilization of the releaxed symphysis pubis of guinea pigs for clues to the mechanism of ovulation. Endocrinology. 1973 Dec;93(6):1441–1445. [PubMed]
  • Unemori EN, Amento EP. Relaxin modulates synthesis and secretion of procollagenase and collagen by human dermal fibroblasts. J Biol Chem. 1990 Jun 25;265(18):10681–10685. [PubMed]
  • Unemori EN, Beck LS, Lee WP, Xu Y, Siegel M, Keller G, Liggitt HD, Bauer EA, Amento EP. Human relaxin decreases collagen accumulation in vivo in two rodent models of fibrosis. J Invest Dermatol. 1993 Sep;101(3):280–285. [PubMed]
  • Unemori EN, Werb Z. Collagenase expression and endogenous activation in rabbit synovial fibroblasts stimulated by the calcium ionophore A23187. J Biol Chem. 1988 Nov 5;263(31):16252–16259. [PubMed]
  • Lindenschmidt RC, Tryka AF, Godfrey GA, Frome EL, Witschi H. Intratracheal versus intravenous administration of bleomycin in mice: acute effects. Toxicol Appl Pharmacol. 1986 Aug;85(1):69–77. [PubMed]
  • Ashcroft T, Simpson JM, Timbrell V. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J Clin Pathol. 1988 Apr;41(4):467–470. [PMC free article] [PubMed]
  • Hesterberg TW, Gerriets JE, Reiser KM, Jackson AC, Cross CE, Last JA. Bleomycin-induced pulmonary fibrosis: correlation of biochemical, physiological, and histological changes. Toxicol Appl Pharmacol. 1981 Sep 15;60(2):360–367. [PubMed]
  • Sporn MB, Roberts AB. TGF-beta: problems and prospects. Cell Regul. 1990 Nov;1(12):875–882. [PMC free article] [PubMed]
  • Unemori EN, Bauer EA, Amento EP. Relaxin alone and in conjunction with interferon-gamma decreases collagen synthesis by cultured human scleroderma fibroblasts. J Invest Dermatol. 1992 Sep;99(3):337–342. [PubMed]
  • Amento EP, Bhan AK, McCullagh KG, Krane SM. Influences of gamma interferon on synovial fibroblast-like cells. Ia induction and inhibition of collagen synthesis. J Clin Invest. 1985 Aug;76(2):837–848. [PMC free article] [PubMed]
  • Khalil N, Bereznay O, Sporn M, Greenberg AH. Macrophage production of transforming growth factor beta and fibroblast collagen synthesis in chronic pulmonary inflammation. J Exp Med. 1989 Sep 1;170(3):727–737. [PMC free article] [PubMed]
  • Khalil N, O'Connor RN, Unruh HW, Warren PW, Flanders KC, Kemp A, Bereznay OH, Greenberg AH. Increased production and immunohistochemical localization of transforming growth factor-beta in idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol. 1991 Aug;5(2):155–162. [PubMed]
  • Mushayandebvu TI, Rajabi MR. Relaxin stimulates interstitial collagenase activity in cultured uterine cervical cells from nonpregnant and pregnant but not immature guinea pigs; estradiol-17 beta restores relaxin's effect in immature cervical cells. Biol Reprod. 1995 Nov;53(5):1030–1037. [PubMed]
  • Eitzman DT, McCoy RD, Zheng X, Fay WP, Shen T, Ginsburg D, Simon RH. Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene. J Clin Invest. 1996 Jan 1;97(1):232–237. [PMC free article] [PubMed]
  • Adamson IY, Bowden DH. Bleomycin-induced injury and metaplasia of alveolar type 2 cells. Relationship of cellular responses to drug presence in the lung. Am J Pathol. 1979 Aug;96(2):531–544. [PMC free article] [PubMed]
  • Phan SH, Thrall RS, Williams C. Bleomycin-induced pulmonary fibrosis. Effects of steroid on lung collagen metabolism. Am Rev Respir Dis. 1981 Oct;124(4):428–434. [PubMed]
  • Mall G, Zimmermann P, Siemens I, Burkhardt A, Otto HF. Prevention of bleomycin-induced fibrosing alveolitis with indomethacin: stereological studies on rat lungs. Virchows Arch A Pathol Anat Histopathol. 1991;419(4):339–347. [PubMed]
  • Smith RE, Strieter RM, Phan SH, Lukacs NW, Huffnagle GB, Wilke CA, Burdick MD, Lincoln P, Evanoff H, Kunkel SL. Production and function of murine macrophage inflammatory protein-1 alpha in bleomycin-induced lung injury. J Immunol. 1994 Nov 15;153(10):4704–4712. [PubMed]
  • Piguet PF, Collart MA, Grau GE, Kapanci Y, Vassalli P. Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis. J Exp Med. 1989 Sep 1;170(3):655–663. [PMC free article] [PubMed]
  • Witschi HP, Tryka AF, Lindenschmidt RC. The many faces of an increase in lung collagen. Fundam Appl Toxicol. 1985 Apr;5(2):240–250. [PubMed]
  • Fulmer JD, Bienkowski RS, Cowan MJ, Breul SD, Bradley KM, Ferrans VJ, Roberts WC, Crystal RG. Collagen concentration and rates of synthesis in idiopathic pulmonary fibrosis. Am Rev Respir Dis. 1980 Aug;122(2):289–301. [PubMed]
  • Cheah SH, Ng KH, Johgalingam VT, Ragavan M. The effects of oestradiol and relaxin on extensibility and collagen organisation of the pregnant rat cervix. J Endocrinol. 1995 Aug;146(2):331–337. [PubMed]
  • Kibblewhite D, Larrabee WF, Jr, Sutton D. The effect of relaxin on tissue expansion. Arch Otolaryngol Head Neck Surg. 1992 Feb;118(2):153–156. [PubMed]
  • Fei DT, Gross MC, Lofgren JL, Mora-Worms M, Chen AB. Cyclic AMP response to recombinant human relaxin by cultured human endometrial cells--a specific and high throughput in vitro bioassay. Biochem Biophys Res Commun. 1990 Jul 16;170(1):214–222. [PubMed]
  • Cronin MJ, Malaska T, Bakhit C. Human relaxin increases cyclic AMP levels in cultured anterior pituitary cells. Biochem Biophys Res Commun. 1987 Nov 13;148(3):1246–1251. [PubMed]
  • Meera P, Anwer K, Monga M, Oberti C, Stefani E, Toro L, Sanborn BM. Relaxin stimulates myometrial calcium-activated potassium channel activity via protein kinase A. Am J Physiol. 1995 Aug;269(2 Pt 1):C312–C317. [PubMed]
  • Masini E, Bani D, Bigazzi M, Mannaioni PF, Bani-Sacchi T. Effects of relaxin on mast cells. In vitro and in vivo studies in rats and guinea pigs. J Clin Invest. 1994 Nov;94(5):1974–1980. [PMC free article] [PubMed]
  • Kalbag SS, Roginsky MS, Jelveh Z, Sulimovici S. Phorbol ester, prolactin, and relaxin cause translocation of protein kinase C from cytosol to membranes in human endometrial cells. Biochim Biophys Acta. 1991 Aug 13;1094(1):85–91. [PubMed]
  • Osheroff PL, Cronin MJ, Lofgren JA. Relaxin binding in the rat heart atrium. Proc Natl Acad Sci U S A. 1992 Mar 15;89(6):2384–2388. [PMC free article] [PubMed]

Articles from The Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

  • Cited in Books
    Cited in Books
    PubMed Central articles cited in books
  • Compound
    Compound
    PubChem Compound links
  • MedGen
    MedGen
    Related information in MedGen
  • PubMed
    PubMed
    PubMed citations for these articles
  • Substance
    Substance
    PubChem Substance links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...